Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
No plan disclosedOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 3 of the 13 calendar months from Oct 2025 to Oct 2026: Nov 2025, Dec 2025 and Mar 2026.
- Largest single sale: $7.7M (2,334,420 shares) of Precigen, Inc. on Mar 30, 2026. Filing
- Last sale before this period: Sep 30, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Precigen, Inc. (PGEN) | Director | Aug 7, 2013 | Mar 31, 2026 |
| Halozyme Therapeutics, Inc. (HALO) | Former 10% owner | Aug 17, 2006 | Aug 28, 2018 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Mar 30, 2026, Precigen, Inc.: sold 4,772,781 shares for $15.8M, no plan disclosed (some held indirectly). 1 filing: 1
- Mar 13, 2026, Precigen, Inc.: 143,678 shares vested (some held indirectly). 1 filing: 1
- Mar 10, 2026, Precigen, Inc.: 28,490 shares awarded (some held indirectly). 1 filing: 1
- Dec 22, 2025, Precigen, Inc.: sold 1,900,036 shares for $7.9M, no plan disclosed (some held indirectly). 1 filing: 1
- Nov 21, 2025, Precigen, Inc.: sold 937,308 shares for $3.6M, no plan disclosed (some held indirectly). 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.